Fundies.
English

PROTAGONIST THERAPEUTICS, INC.

EDGAR
PTGX Quarterly report (10-Q) · filed 2026-08-05

79 filing records in this dataset, filed from 2016-07-11 to 2026-08-05. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments
Watchlist

Latest quarter

Revenue

213 million Unit_Standard_USD_77i98UF_vkKEAjfCn9RD2w

2026 Q2 · Unit_Standard_USD_77i98UF_vkKEAjfCn9RD2w

Exact inputs and evidence
  • Revenue: 213475000 Unit_Standard_USD_77i98UF_vkKEAjfCn9RD2w Source

Operating margin

74.37%

2026 Q2 · %

Exact inputs and evidence
  • Operating Income: 158766000 Unit_Standard_USD_77i98UF_vkKEAjfCn9RD2w Source
  • Revenue: 213475000 Unit_Standard_USD_77i98UF_vkKEAjfCn9RD2w Source
Cash and cash equivalents
420 million Unit_Standard_USD_77i98UF_vkKEAjfCn9RD2w Source
Exact value

420078000 Unit_Standard_USD_77i98UF_vkKEAjfCn9RD2w

Long-term debt including current maturities
9.83 million Unit12 Source
Exact value

9832000 Unit12

Shares outstanding
64.7 million Unit_Standard_shares_WV5nI_UqiEKNOrulHEyXKQ Source
Exact value

64672032 Unit_Standard_shares_WV5nI_UqiEKNOrulHEyXKQ

Company performance

Up to ten complete financial years · consolidated figures

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-08-05.

Financial data available through: 2025-12-31.

Coverage by financial measure
  • revenue: No compatible figures in this window
  • Operating income: 3 of 11 periods available· newest 2025-12-31
  • Net income: 3 of 11 periods available· newest 2025-12-31
  • Operating cash flow: 3 of 11 periods available· newest 2025-12-31
  • Capital expenditure: 3 of 11 periods available· newest 2025-12-31
  • Total assets: Multiple units; comparison withheld· newest 2025-12-31
  • Total liabilities: Multiple units; comparison withheld· newest 2025-12-31
  • Current assets: Multiple units; comparison withheld· newest 2025-12-31
  • Current liabilities: Multiple units; comparison withheld· newest 2025-12-31
  • Cash and cash equivalents: Multiple units; comparison withheld· newest 2025-12-31
  • Long-term debt including current maturities: Multiple units; comparison withheld· newest 2019-12-31
  • Shares outstanding: Multiple units; comparison withheld· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Net income

    -147.3%

    Prior period

    Unit_Standard_USD_0BPbMdKuT0SNlRCNOy_wbw 275.19 million

    –

    Current period

    −Unit_Standard_USD_0BPbMdKuT0SNlRCNOy_wbw 130.15 million

    –

    Exact inputs and evidence

    -130149000 − 275188000 = -405337000 Unit_Standard_USD_0BPbMdKuT0SNlRCNOy_wbw

    275188000 Unit_Standard_USD_0BPbMdKuT0SNlRCNOy_wbw · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    -130149000 Unit_Standard_USD_0BPbMdKuT0SNlRCNOy_wbw · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    -68.7%

    Prior period

    Unit_Standard_USD_0BPbMdKuT0SNlRCNOy_wbw 184.15 million

    –

    Current period

    Unit_Standard_USD_0BPbMdKuT0SNlRCNOy_wbw 57.67 million

    –

    Exact inputs and evidence

    57671000 − 184152000 = -126481000 Unit_Standard_USD_0BPbMdKuT0SNlRCNOy_wbw

    184152000 Unit_Standard_USD_0BPbMdKuT0SNlRCNOy_wbw · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    57671000 Unit_Standard_USD_0BPbMdKuT0SNlRCNOy_wbw · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Capital expenditure

    +17.3%

    Prior period

    Unit_Standard_USD_0BPbMdKuT0SNlRCNOy_wbw 1.36 million

    –

    Current period

    Unit_Standard_USD_0BPbMdKuT0SNlRCNOy_wbw 1.59 million

    –

    Exact inputs and evidence

    1590000 − 1355000 = 235000 Unit_Standard_USD_0BPbMdKuT0SNlRCNOy_wbw

    1355000 Unit_Standard_USD_0BPbMdKuT0SNlRCNOy_wbw · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    1590000 Unit_Standard_USD_0BPbMdKuT0SNlRCNOy_wbw · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

Revenue is not reported for this company, so its costs cannot be shown as a share of it.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Not enough comparable data to show this history.
Values and sources
Revenue values and source evidence
PeriodSeriesValueSource evidence

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValueSource evidence

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(Unit_Standard_USD_0BPbMdKuT0SNlRCNOy_wbw)Source evidence

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2023 2023-01-01 – 2023-12-31
−Unit_Standard_USD_0BPbMdKuT0SNlRCNOy_wbw 78.96 million
Exact value

Exact value: -78955000 Unit_Standard_USD_0BPbMdKuT0SNlRCNOy_wbw

2023-01-01 – 2023-12-31: -78955000 Unit_Standard_USD_0BPbMdKuT0SNlRCNOy_wbw Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−Unit_Standard_USD_0BPbMdKuT0SNlRCNOy_wbw 70.24 million
Exact value

Exact value: -70236000 Unit_Standard_USD_0BPbMdKuT0SNlRCNOy_wbw

2023-01-01 – 2023-12-31: -70236000 Unit_Standard_USD_0BPbMdKuT0SNlRCNOy_wbw Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unit_Standard_USD_0BPbMdKuT0SNlRCNOy_wbw 609,000
Exact value

Exact value: 609000 Unit_Standard_USD_0BPbMdKuT0SNlRCNOy_wbw

2023-01-01 – 2023-12-31: 609000 Unit_Standard_USD_0BPbMdKuT0SNlRCNOy_wbw Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−Unit_Standard_USD_0BPbMdKuT0SNlRCNOy_wbw 70.85 million
Calculation and evidence

-70236000 − 609000 Unit_Standard_USD_0BPbMdKuT0SNlRCNOy_wbw

Exact free cash flow: -70845000 Unit_Standard_USD_0BPbMdKuT0SNlRCNOy_wbw

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2024 2024-01-01 – 2024-12-31
Unit_Standard_USD_0BPbMdKuT0SNlRCNOy_wbw 275.19 million
Exact value

Exact value: 275188000 Unit_Standard_USD_0BPbMdKuT0SNlRCNOy_wbw

2024-01-01 – 2024-12-31: 275188000 Unit_Standard_USD_0BPbMdKuT0SNlRCNOy_wbw Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unit_Standard_USD_0BPbMdKuT0SNlRCNOy_wbw 184.15 million
Exact value

Exact value: 184152000 Unit_Standard_USD_0BPbMdKuT0SNlRCNOy_wbw

2024-01-01 – 2024-12-31: 184152000 Unit_Standard_USD_0BPbMdKuT0SNlRCNOy_wbw Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unit_Standard_USD_0BPbMdKuT0SNlRCNOy_wbw 1.36 million
Exact value

Exact value: 1355000 Unit_Standard_USD_0BPbMdKuT0SNlRCNOy_wbw

2024-01-01 – 2024-12-31: 1355000 Unit_Standard_USD_0BPbMdKuT0SNlRCNOy_wbw Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unit_Standard_USD_0BPbMdKuT0SNlRCNOy_wbw 182.8 million
Calculation and evidence

184152000 − 1355000 Unit_Standard_USD_0BPbMdKuT0SNlRCNOy_wbw

Exact free cash flow: 182797000 Unit_Standard_USD_0BPbMdKuT0SNlRCNOy_wbw

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2025 2025-01-01 – 2025-12-31
−Unit_Standard_USD_0BPbMdKuT0SNlRCNOy_wbw 130.15 million
Exact value

Exact value: -130149000 Unit_Standard_USD_0BPbMdKuT0SNlRCNOy_wbw

2025-01-01 – 2025-12-31: -130149000 Unit_Standard_USD_0BPbMdKuT0SNlRCNOy_wbw Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unit_Standard_USD_0BPbMdKuT0SNlRCNOy_wbw 57.67 million
Exact value

Exact value: 57671000 Unit_Standard_USD_0BPbMdKuT0SNlRCNOy_wbw

2025-01-01 – 2025-12-31: 57671000 Unit_Standard_USD_0BPbMdKuT0SNlRCNOy_wbw Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unit_Standard_USD_0BPbMdKuT0SNlRCNOy_wbw 1.59 million
Exact value

Exact value: 1590000 Unit_Standard_USD_0BPbMdKuT0SNlRCNOy_wbw

2025-01-01 – 2025-12-31: 1590000 Unit_Standard_USD_0BPbMdKuT0SNlRCNOy_wbw Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unit_Standard_USD_0BPbMdKuT0SNlRCNOy_wbw 56.08 million
Calculation and evidence

57671000 − 1590000 Unit_Standard_USD_0BPbMdKuT0SNlRCNOy_wbw

Exact free cash flow: 56081000 Unit_Standard_USD_0BPbMdKuT0SNlRCNOy_wbw

Share or cite

The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

79 filings · 4,000 latest values · 4,000 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001377121, 1377121, PTGX, edgar:1377121

Also known as PROTAGONIST THERAPEUTICS, INC, PROTAGONIST THERAPEUTICS, INC., PROTAGONIST THERAPEUTICS, INC., Protagonist Inc, Protagonist Therapeutics Inc, Protagonist Therapeutics, Inc